Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:

Vericel Corproation (VCEL)

Vericel Corproation (VCEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Vericel Corporation (VCEL) Surges 16.3%: Is This an Indication of Further Gains? Zacks - Wed Jan 11, 9:24PM CST

Vericel Corporation (VCEL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

VCEL : 27.85 (-0.21%)
ABUS : 2.93 (+2.09%)
Kytopen Appoints Paul K. Wotton, Ph.D. to Chair of Board of Directors Business Wire - Thu Jan 5, 8:00AM CST

Kytopen , an MIT-spin out and biotechnology company leading advancements in novel high-throughput cellular and genome engineering platforms, today announced the appointment of Paul K. Wotton, Ph.D. to...

VCEL : 27.85 (-0.21%)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027 FinancialNewsMedia - Tue Nov 15, 2022

EQNX::TICKER_START (OTCQB:OCEL),(NASDAQ:BRTX),(NASDAQ:MDXG),(NYSE:NNVC),(NASDAQ:VCEL) EQNX::TICKER_END

VCEL : 27.85 (-0.21%)
OCEL : 0.0178 (-1.11%)
BRTX : 3.02 (-1.17%)
MDXG : 3.81 (+7.32%)
NNVC : 1.4500 (unch)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027 PR Newswire - Tue Nov 15, 2022

/PRNewswire/ -- Chronic obstructive pulmonary disease is a chronic lung disease that prevents airflow from the lungs. The rising incidence of COPD is one...

OCEL : 0.0178 (-1.11%)
BRTX : 3.02 (-1.17%)
MDXG : 3.81 (+7.32%)
NNVC : 1.4500 (unch)
VCEL : 27.85 (-0.21%)
Vericel Corporation (VCEL) Reports Q3 Loss, Lags Revenue Estimates Zacks - Wed Nov 9, 2022

Vericel Corporation (VCEL) delivered earnings and revenue surprises of -16.67% and 3.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

VCEL : 27.85 (-0.21%)
IMTX : 7.81 (-4.76%)
Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates Zacks - Tue Nov 8, 2022

Zymeworks Inc. (ZYME) delivered earnings and revenue surprises of 23.40% and 44.44%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ZYME : 9.75 (-0.31%)
VCEL : 27.85 (-0.21%)
Cardiff Oncology (CRDF) Reports Q3 Loss, Tops Revenue Estimates Zacks - Thu Nov 3, 2022

Cardiff Oncology (CRDF) delivered earnings and revenue surprises of 25.93% and 24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CRDF : 1.7300 (+0.58%)
VCEL : 27.85 (-0.21%)
How Much Upside is Left in Vericel Corporation (VCEL)? Wall Street Analysts Think 53% Zacks - Tue Aug 9, 2022

The average of price targets set by Wall Street analysts indicates a potential upside of 52.8% in Vericel Corporation (VCEL). While the effectiveness of this highly sought-after metric is questionable,...

VCEL : 27.85 (-0.21%)
Vericel (VCEL) Q2 2022 Earnings Call Transcript Motley Fool - Thu Aug 4, 2022

VCEL earnings call for the period ending June 30, 2022.

VCEL : 27.85 (-0.21%)
Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates Zacks - Wed Aug 3, 2022

Vericel Corporation (VCEL) delivered earnings and revenue surprises of -46.15% and 3.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

VCEL : 27.85 (-0.21%)
KYMR : 35.48 (-3.51%)

Barchart Exclusives

2 Unusually Active Tesla Call Options. Only 1 Is a Buy Barchart - Thu Jan 26, 12:00PM CST
Two Tesla call options expiring in March 2024 exhibited unusual options activity Wednesday. Only one of them is a buy.    Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot